Board of Directors Scientific Advisory Panel  Debra Black, Chair; Co-Founder, MRA;  Christopher Austin, M.D., Senior Advisor for Broadway Producer; Melanoma Survivor Translational Research, National Institutes of  Leon Black, Co-Founder, MRA; Board Member, Health FasterCures; Founding Partner, CEO and Chair,  Paul Billings, M.D., Ph.D., Chief Medical Officer, Apollo Management LP Life Technologies  Maria Bell, Head Writer & Co-Executive  Gideon Bollag, Ph.D., Senior Vice President of Producer, The Young & the Restless Research, Plexxikon, Inc.  Jason Federici, Art Director, Graphic Designer, Photographer  Lynda Chin, M.D., Professor and Chair,  Jami Gertz, TV and Film Actress Department of Genomic Medicine; Scientific  Susan Hess, Vice Chairman, Whitney Museum Director, Institute for Applied Cancer Science,  Michael Klowden, President and CEO, Milken University of Texas M.D. Anderson Cancer Institute Center  Connie Mack, Senior Policy Advisor, Liberty  Richard Gaynor, M.D., Vice President, Partners Group LLC; Former U.S. Senator Oncology, Product Development and Medical  Nancy Marks, Artist Affairs, Eli Lilly  Michael Milken, Chairman, Milken Institute; Founder and Chairman, FasterCures; Founder  Donald Morton, M.D. Chief, Melanoma and Chairman, Prostate Cancer Foundation Program, Director, Surgical Oncology  Richard Ressler, Founder, Orchard Capital Fellowship Program, John Wayne Cancer Corporation and CIM Group Institute  Jeff Rowbottom, Managing Director & Co-head  Neal Rosen, M.D., Ph.D., Enid A. Haupt Chair in of North America Capital Markets, KKR Medical Oncology, Memorial Sloan-Kettering  Gregory C. Simon Cancer Center  Jonathan W. Simons, M.D., President and CEO, David H. Koch Chair, Prostate Cancer  Steven Rosenberg, M.D., Chief, Surgery Branch Foundation; Professor, Biomedical Engineering National Cancer Institute and Material Sciences, Georgia Institute of  Joshua Sharfstein, M.D., State of Maryland, Technology, NCI Center of Cancer Secretary of Health & Mental Hygiene, Office of Nanotechnology Excellence Secretary, Department of Health & Mental  Jonathan Sokoloff, Managing Partner, Leonard Hygiene Green & Partners, LP  Suzanne Topalian, M.D., Professor of Surgery  Elizabeth Stanton, President, Oliver and Elizabeth Stanton Foundation and Oncology, Johns Hopkins Medicine;  Margaret Anderson, Secretary; Executive Director, Melanoma Program, Sidney Kimmel Director, FasterCures Comprehensive Cancer Center, Johns Hopkins  Kamyab Hashemi-Nejad, Treasurer; Director of University Finance, Milken Institute  Wendy K.D. Selig, MRA President and CEO  Wendy K. D. Selig, President and CEO, MRA

Grant Review Committee  Thomas Gajewski, M.D., Ph.D., Associate  Glenn Dranoff, M.D., – Chair, Director, Human Professor, Departments of Pathology and Gene Transfer Laboratory Core, Dana-Farber Medicine, University of Chicago; Director, Cancer Institute Immunology and Cancer Program, University of Chicago Comprehensive Cancer Center  David Solit, M.D. – Co-Chair, Assistant Member,  Human Oncology and Pathogenesis Program; Allan Halpern, M.D., Chief, Dermatology Service, Elizabeth and Felix Rohatyn Chair for Junior Memorial Sloan-Kettering Cancer Center Faculty, Memorial Sloan-Kettering Cancer Center  Meenhard Herlyn, D.V.M, D.Sc., Professor and  James Allison, Ph.D., Chair of Immunology Program Leader, Molecular and Cellular Program, Memorial Sloan-Kettering Cancer Oncogenesis Program, The Wistar Institute Center; Director of Ludwig Center for Cancer,  Thomas Hornyak, M.D., Ph.D., Chief, Immunotherapy; Investigator, Howard Hughes Dermatology, VA Maryland Health Care System; Medical Center Associate Professor of Dermatology and  Boris Bastian, M.D., Clinical Professor, Biochemistry and Molecular Biology, University Department Dermatology, University of of Maryland School of Medicine California, San Francisco  Michal Lotem, M.D., Sharret Institute of  Marcus Bosenberg, M.D., Ph.D., Associate Oncology, Hadassah Hebrew University Hospital Professor of Dermatology and Pathology, Yale  Richard Marais, Ph.D., Director, Paterson School of Medicine Institute for Cancer Research  Steven Burakoff, M.D., Professor of Medicine,  Kim Margolin, M.D., Physician, University of Hematology and Medical Oncology; Professor, Washington/Seattle Cancer Center Oncological Sciences, Mount Sinai School of  Martin McMahon, Ph.D., Professor-In-Residence, Medicine University of California, San Francisco  Jonathan Cebon, MBBS, FRACP., Ph.D., Director,  Glenn Merlino, Ph.D., Chief, Laboratory of Cancer Medical Oncology Austin Health; Head Cancer Biology and Genetics, National Cancer Institute, Vaccine Laboratory, Ludwig Institute for Cancer NIH Research, Melbourne; Professor of Medicine,  Antoni Ribas, M.D., Ph.D., Associate Professor, University of Melbourne University of California, Los Angeles  Paul Chapman, M.D., Attending Physician,  Stan Riddell, M.D., Member, Department of Melanoma/Sarcoma service, Memorial Sloan- Immunology, Fred Hutchinson Cancer Research Kettering Cancer Center; Professor of Medicine, Center Weill Medical College of Cornell University  Caroline Robert, M.D., Ph.D., Professor of  Tanja de Gruijl, Ph.D., Associate Professor, VU Dermatology, Head of the Dermatology Unit, University Medical Center Institute Gustave Roussy  Charles Drake, M.D., Ph.D., Associate Professor,  Lynn Schucter, M.D., C. Willard Robinson Oncology, Immunology and Urology; Director - Professor of Hematology-Oncology; Attending Multidisciplinary Prostate Cancer Clinic, Johns Physician, Hospital of the University of Hopkins Sidney Kimmel Comprehensive Cancer Pennsylvania; Program Leader: Melanoma Center Program, Abramson Cancer Center of the  Levi Garraway, M.D., Ph.D., Assistant Professor of University of Pennsylvania; Division Chief, Medicine, Dana-Farber Cancer Institute; Associate Hematology-Oncology, University of Member, Broad Institute Pennsylvania

Grant Review Committee  Jonathan Simons, M.D., CEO and President, David H. Koch Chair, Prostate Cancer Foundation  Howard Soule, Ph.D., Executive Vice President, Discovery and Translation, Prostate Cancer Foundation  Suzanne Topalian, M.D., MRA Chief Science Officer, Professor of Surgery and Oncology, Johns Hopkins Medicine; Director, Melanoma Program, Sidney Kimmel Comprehensive Cancer Center  Michael Weber, Ph.D., Director, Cancer Center, Weaver Professor of Oncology, University of Virginia

Medical Advisory Panel  Paul Chapman, M.D. – Chair, Attending  Kim Margolin, M.D., Professor, Department of Physician, Melanoma/Sarcoma Service, Medicine, University of Washington/Seattle Cancer Memorial Sloan-Kettering Cancer Center; Center Professor of Medicine, Weill Medical College of  Antoni Ribas, M.D., Ph.D., Professor of Medicine, Cornell University University of California Los Angeles  David Fisher, M.D., Ph.D., Chief, Department of  Lynn Schuchter, M.D., C. Willard Robinson Dermatology, Director, Melanoma Program, Professor of Hematology-Oncology; Attending MGH Cancer Center Director, Cutaneous Biology Physician, Hospital of the University of Research Center, Massachusetts General Pennsylvania; Program Leader: Melanoma Hospital; Edward Wigglesworth Professor of Program, Abramson Cancer Center of the Dermatology, Harvard Medical School University of Pennsylvania; Division Chief,  Thomas Gajewski, M.D., Ph.D., Professor, Hematology-Oncology, University of Pennsylvania Departments of Pathology and Medicine,  Suzanne Topalian, M.D., MRA Chief Science Officer; University of Chicago Professor of Surgery and Oncology, Johns Hopkins  Jeffrey Gershenwald, M.D., Professor, University Medicine; Director, Melanoma Program, Sidney of Texas M.D. Anderson Cancer Center Kimmel Comprehensive Cancer Center  F. Stephen Hodi, M.D., Assistant Professor,  Jedd Wolchok, M.D., Ph.D., Associate Professor, Department of Medicine, Harvard Medical Memorial Sloan-Kettering Cancer Center School; Assistant Professor of Medicine, Dana- Farber Cancer Institute Updated: September 2012  Roger Lo, M.D., Ph.D., Director, Melanoma Clinic in Dermatology, Assistant Clinical Professor of Medicine, Dermatology, University of California Los Angeles

 Patricia LoRusso, D.O., Professor of Medicine, Barbara Ann Karmanos Cancer Institute